Surveillance of endophthalmitis following cataract surgery in the UK

Eye

Volumn 18, Issue 6, 2004, Pages 580-587

  Kamalarajah, S ^a,b   Silvestri, G ^a   Sharma, N ^b   Khan, A ^c   Foot, B ^d   Ling, R ^e   Cran, G ^f   Best, R ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b ALTNAGELVIN HOSPITAL   (United Kingdom)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

^d Royal College of Opthalmologists   (United Kingdom)

^e TORBAY HOSPITAL   (United Kingdom)

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cataract surgery; Endophthalmitis; Infection; Surveillance

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BETAMETHASONE; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; DEXAMETHASONE; GENTAMICIN; PREDNISOLONE; STEROID; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BLINDNESS; CATARACT EXTRACTION; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DATA BASE; DRUG CHOICE; ENDOPHTHALMITIS; EPIDEMIOLOGICAL DATA; EYE INFECTION; EYE SURGERY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROSPECTIVE STUDY; QUESTIONNAIRE; SCHOOL CHILD; STANDARD; STREPTOCOCCUS; TREATMENT OUTCOME; UNITED KINGDOM; VISUAL ACUITY; VITRECTOMY;

EID: 3242727827     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6700645     Document Type: Article

References (24)

1. Fisch A, Salvanet A, Prazuck T, Forestier F, Gerbaud L, Coscas G et al. Epidemiology of infective endophthalmitis in France. The French Collaborative Study Group on Endophthalmitis. Lancet 1991; 338(8779): 1373-1376.
2. Schmitz S, Dick HB, Krummenauer F, Pfeiffer N. Endophthalmitis in cataract surgery: results of a German survey. Ophthalmology 1999; 106(10): 1869-1877.
3. Aaberg Jr TM, Flynn Jr HW, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology 1998; 105(6): 1004-1010.
4. Desai P, Minassian D.C, Reidy A. National cataract surgery survey 1997-1998: a report of the results of the clinical outcomes. Br J Ophthalmol 1999; 83: 1336-1340.
5. Foot B, Stanford M, Rahi J, Thompson J. The British Ophthalmological Surveillance Unit: an evaluation of the first 3 years. Eye 2003; 17: 9-15.
6. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 1995; 113: 1479-1496.
7. Thacker SB, Redmond S, Berkelman RL. A controlled trial of disease surveillance strategies. Am J Prev Med 1986; 2: 345-350.
8. Vogt RL, LaRue D, Klaucke DN, Jillison DA. Comparison of an active and passive surveillance system of primary care providers for hepatitis, measles, rubella and salmonellosis in Vermont. Am J Public Health 1983; 73: 795-797.
9. Foot BG, Stanford MR. Questioning Questionnaires. Eye 2001; 15: 693-694.
10. Hughes DS, Hill RJ. Infectious endophthalmitis after cataract surgery. Br J Ophthalmol 1994; 78(3): 227-232.
11. Olson JC, Flynn Jr HW, Forster RK, Culbertson WW. Results in the treatment of postoperative endophthalmitis. Ophthalmology 1983; 90(6): 692-699.
12. Okhravi N, Adamson P, Matheson MM, Towler HM, Lightman S. PCR-RFLP-mediated detection and speciation of bacterial species causing endophthalmitis. Invest Ophthalmol Vis Sci 2000; 41(6): 1438-1447.
13. Hykin PG, Tobal K, McIntyre G, Matheson MM, Towler HM, Lightman SL. The diagnosis of delayed post-operative endophthalmitis by polymerase chain reaction of bacterial DNA in vitreous samples. J Med Microbiol 1994; 40(6): 408-415.
14. Therese KL, Anand AR, Madhavan HN. Polymerase chain reaction in the diagnosis of bacterial endophthalmitis. Br J Ophthalmol 1998; 82(9): 1078-1082.
15. Barza M, Pavan PR, Doft BH, Wisniewski SR, Wilson LA, Han DP et al. Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 1997; 115(9): 1142-1150.
16. Peyman GA. Antibiotic administration in the treatment of bacterial endophthalmitis. II. Intravitreal injections. Surv Ophthalmol 1977; 21(4): 332, 339-346.
17. Davidson SI. Post-operative bacterial endophthalmitis. Trans Ophthalmol Soc UK 1985; 104(Part 3): 278-284.
18. Okhravi N, Towler HM, Hykin P, Matheson M, Lightman S. Assessment of a standard treatment protocol on visual outcome following presumed bacterial endophthalmitis. Br J Ophthalmol 1997; 81(9): 719-725.
19. Murray DC, Christopoulou D, Hero M. Intravitreal penetration of teicoplanin (letter; comment). Eye 1999; 13(Part 4): 604-605.
20. Campochiaro PA, Conway BP. Aminoglycoside toxicity - a survey of retinal specialists. Implications for ocular use (see comments). Arch Ophthalmol 1991; 109(7): 946-950.
21. Park SS, Vallar RV, Hong CH, von Gunten S, Ruoff K, D'Amico DJ. Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis. Arch Ophthalmol 1999; 117(8): 1058-1062.
22. Shah GK, Stein JD, Sharma S, Sivalingam A, Benson WE, Regillo CD et al. Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology 2000; 107(3): 486-489.
23. Harris MJ. Visual outcome after intravitreal steroid use for postoperative endophthalmitis. Ophthalmology 2001; 108(2): 240-241.
24. The Royal College of Ophthalmologists. Guidance for Clinical Governance in Ophthalmology. 8. 1999. Ref Type: Report.